Revelation Biosciences (REVB) Payables (2020 - 2026)
Revelation Biosciences' Payables came in at $931,093 for Q2 2026, up 12.3% from $828,894 a year earlier and up 12.4% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Revelation Biosciences' Payables was $577,501, down 26.3% from FY2024.
- Payables carries a five-year compound annual growth rate of 76.4% (FY2020 to FY2025).
- Going back by year, Payables was $783,621 in FY2024 (-42.4%), $1.36 million in FY2023 (+145.4%), $554,205 in FY2022 (-59.6%) and $1.37 million in FY2021.
- The five-year range for quarterly Payables is $466,084 (Q3 2022) to $3.13 million (Q3 2024).
- Year-over-year, Payables increased in three of the last eight quarters, with an average decline of 5.0%.
- The fastest year-over-year change in Payables over five years came in Q1 2022 (growth of 280.8%), and the weakest in Q3 2022 (a decline of 70.8%).
- Business Quant data shows REVB's Payables at $828,203 (Q1 2026), $577,501 (Q4 2025) and $1.03 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Revelation Biosciences | 3.36 Mn | -45.66 Mn | - | 931,093.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 931,093.00 |
| Mar 31, 2026 | 828,203.00 |
| Dec 31, 2025 | 577,501.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 828,894.00 |
| Mar 31, 2025 | 625,058.00 |
| Dec 31, 2024 | 783,621.00 |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 913,866.00 |
| Mar 31, 2023 | 705,089.00 |
| Dec 31, 2022 | 554,205.00 |
| Sep 30, 2022 | 466,084.00 |
| Jun 30, 2022 | 916,475.00 |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.59 Mn |
API Access
Revelation Biosciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();